A pharmacy-based intervention could prevent heart failure in primary care, US
What is the aim?
The study uses the PCP-HF protocol to predict heart failure risk of 5% or higher over a 10-year period using measures available in primary care settings. People at risk of heart failure will be monitored with biomarker testing and echocardiography as well as health and lifestyle questionnaires.
What has been achieved?
The study is ongoing. Participants have been assigned to usual care or one-year pharmacist-led interventions in which a pharmacist, under the supervision of a cardiologist, recommends therapy initiation and adjustments to optimise the management of heart failure risk factors (e.g. hypertension, cholesterol).
Wang MC, Dolan B, Freed BH, et al. 2021. Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study. Front Cardiovasc Med 8: 785109